Vitamin D-based Multiple Sclerosis Therapy Shows Promise in Mouse Model Study

In a mouse model study biochemists at the University of Wisconsin-Madison have discovered a promising vitamin D-based treatment that may stop and even reverse the progression of multiple sclerosis (MS). The disease typically takes hold of its patients around age 30, relegating them to the use of a mobility aid by middle age and leaving them bed-bound by age 60. The treatment, noted in a recent edition of Journal of Neuroimmunology, includes a protocol of calcitriol, the active hormone found in vitamin D and vitamin D supplements. “All of the animals just got better and better, and the longer we watched them, the more neurological function they regained,” says biochemistry professor Colleen Hayes, who led the study. Click here to read the full story.